Finland · Delayed Price · Currency is EUR Neste Oyj Earnings Call Transcripts
Fiscal Year 2026
-
Strong Q1 performance driven by high margins in Renewable and Oil Products, despite lower utilization from planned turnarounds. Regulatory tailwinds in the U.S. and Europe, robust cash flow, and progress on major investments position the company well for continued volatility.
Fiscal Year 2025
-
Strong 2025 results with EBITDA up over EUR 400 million year-over-year and all segments improving. Regulatory tailwinds and a successful performance improvement program support a positive outlook, though feedstock volatility and maintenance will impact 2026.
-
Q3 saw strong EBITDA, improved margins, and record SAF sales, with the Performance Improvement Programme ahead of schedule. Regulatory momentum in Europe and disciplined CapEx support a positive outlook, though maintenance and feedstock volatility present near-term challenges.
-
Q2 delivered record renewable volumes and strong cash flow, with the performance improvement program on track and regulatory tailwinds emerging. Rotterdam expansion and positive regulatory developments in Europe and the U.S. are key strategic drivers.
-
Q1 2025 saw solid refinery operations, initial cost savings from the performance program, and strong SAF sales momentum. Profitability remains below target due to high feedstock costs and market oversupply, but further improvements are expected as cost initiatives and new capacity ramp up.
-
Management is implementing a €350 million EBITDA improvement program, focusing on cost reduction, asset optimization, and capital discipline. Rotterdam expansion is delayed and over budget, but long-term growth in renewables is expected, with regulatory support and feedstock strategy as key drivers.
Fiscal Year 2024
-
2024 saw a sharp decline in earnings and margins due to overcapacity, operational issues, and market normalization. A new performance program and cost-cutting measures are being implemented, with higher sales volumes and continued investment in renewables expected for 2025.
-
Q3 2024 saw a sharp drop in profitability due to weaker markets, despite higher sales volumes and cost savings. The company is prioritizing operational improvements, cost discipline, and a full potential analysis, while maintaining strong liquidity and advancing major projects.
-
Q2 2024 saw a sharp EBITDA decline due to weak renewables markets and a major turnaround, but operational execution and cost efficiency improved. SAF sales are set to rise in H2, with regulatory support and capacity ramp-ups expected to drive long-term growth.
-
Renewables margin guidance for 2024 was revised down due to weaker Q2 market conditions, with SAF sales and production expected to increase in H2. Martinez ramp-up and regulatory progress remain key, while cost efficiency and product optimization are ongoing priorities.